• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Terreno Realty Corporation Announces Lease Renewal in Washington, D.C.

    5/20/25 9:15:00 AM ET
    $TRNO
    Real Estate
    Finance
    Get the next $TRNO alert in real time by email

    Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, announced today that it has executed a lease renewal for 53,000 square feet in Washington, D.C. with the United States Postal Service. The renewal lease will commence June 1, 2025 and expire June 2030.

    Terreno Realty Corporation acquires, owns and operates industrial real estate in six major coastal U.S. markets: New York City/Northern New Jersey; Los Angeles; Miami; San Francisco Bay Area; Seattle; and Washington, D.C.

    Additional information about Terreno Realty Corporation is available on the company's web site at www.terreno.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws. We caution investors that forward-looking statements are based on management's beliefs and on assumptions made by, and information currently available to, management. When used, the words "anticipate," "believe," "estimate," "expect," "intend," "may," "might," "plan," "project," "result," "should," "will," "seek," "target," "see," "likely," "position," "opportunity," "outlook," "potential," "enthusiastic," "future" and similar expressions which do not relate solely to historical matters are intended to identify forward-looking statements. These statements are subject to risks, uncertainties, and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties, and factors that are beyond our control, including risks related to our ability to meet our estimated forecasts related to stabilized cap rates and those risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2024 and our other public filings. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated, or projected. We expressly disclaim any responsibility to update our forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on results and trends at the time they are made, to anticipate future results or trends.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250519537685/en/

    Jaime Cannon

    415-655-4580

    Get the next $TRNO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TRNO

    DatePrice TargetRatingAnalyst
    4/7/2025$61.00Overweight → Neutral
    Piper Sandler
    2/21/2025$65.00 → $77.00Neutral → Buy
    Goldman
    2/4/2025$71.00Market Perform
    BMO Capital Markets
    1/14/2025$60.00Hold
    Deutsche Bank
    1/13/2025$68.00 → $60.00Overweight → Equal Weight
    Barclays
    9/5/2024$62.00Neutral → Underperform
    Mizuho
    8/28/2024$71.00 → $75.00Overweight → Equal Weight
    Wells Fargo
    6/4/2024$68.00Outperform
    Exane BNP Paribas
    More analyst ratings